A Modified Minimally Invasive Approach Towards Le Fort I Osteotomy: a Prospective Study
MILF-I
1 other identifier
observational
20
1 country
1
Brief Summary
Nowadays, maxillary Le Fort I osteotomy is a safe and routinely performed procedure. The conventional approach is characterized by a vestibular incision extending from molar-to-molar, associated with a pterygomaxillary disjunction performed with a curved chisel. Adequate mobilization of the maxilla during Le Fort I osteotomy requires an effective separation of the maxillary tuberosity from the pterygoid plates of the sphenoid bone. However, as initially described by Precious (1991) and later by Hernandez-Alfaro (2013), a true pterygomaxillary osteotomy is not necessary to achieve successful disjunction. Furthermore, Hernandez-Alfaro combined his technique of pterygomaxillary disjunction, the so-called "Twist technique", to a minimally invasive protocol, performing the complete Le Fort I osteotomy through a 20 to 30 mm long horizontal vestibular incision. Although promising, the technique remains highly sensitive from a technical standpoint, and its true accuracy has not been comprehensively evaluated. The purpose of this study is to present and validate a minimally invasive approach towards Le Fort I osteotomy, using a modified pterygomaxillary (PTM) disjunction technique. The primary outcome is to evaluate the accuracy of the technique using rigid voxel-based registration of the 3D virtual treatment planning and the 4 weeks postoperative CBCT images. Secondary outcomes include the surgical time necessary to complete the procedure and the presence of intraoperative and early postoperative complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 11, 2016
CompletedFirst Posted
Study publicly available on registry
January 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedJanuary 19, 2021
January 1, 2021
5.1 years
January 11, 2016
January 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
accuracy of the minimally invasive approach in comparison to conventional approaches, based on 3D virtual CBCT superimposition of planning CBCT and postoperative CBCT
at 4 weeks postoperative
Secondary Outcomes (2)
Surgical time necessary to complete the procedure
perioperative
Intraoperative and early postoperative complications
within 4 weeks postoperative
Eligibility Criteria
All consenting patients requiring a bimaxillary orthognathic procedure as part of their orthodontic-surgical treatment plan, and satisfying the inclusion and exclusion criteria.
You may qualify if:
- Patients of all ages
- Patients of all genders
- A Le Fort I osteotomy is planned, as part of a bimaxillary orthognathic procedure
- The surgery is planned with 3D Virtual Treatment Planning (Maxilim v. 2.3.0.3.0.)
- The planning is transferred with 3D CAD/CAM tooth-borne splint and vertical internal bony reference landmarks
- The maxilla is repositioned first during the surgery (maxilla first sequence)
You may not qualify if:
- Patients not eligible according to abovementioned criteria
- Simultaneous extraction of impacted teeth 18 and/or 28
- Previous maxillary orthognathic surgery
- Previous Surgical Assisted Rapid Palatal Expansion (SARPE)
- Syndromic condition, including cleft lip and palate
- Segmental Le Fort I osteotomy
- Adjuvant Zygomatic osteotomy
- Maxillary impaction higher than 3 mm
- Maxillary advancement greater than 5 mm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AZ Sint-Jan AVlead
Study Sites (1)
general hospital Saint-John Bruges
Bruges, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gwen Swennen
Division of Maxillofacial Surgery, Department of Surgery, General Hospital Saint-John Bruges, Belgium
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Maxillofacial Surgeon, MD, LDS, DMD, PhD, FEBOMFS
Study Record Dates
First Submitted
January 11, 2016
First Posted
January 21, 2016
Study Start
November 1, 2014
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
January 19, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share